(Q58289900)

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Subcellular localization and analysis of apparent 180-kDa and 220-kDa proteins of the breast cancer susceptibility gene, BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Growth retardation and tumour inhibition by BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Double indemnity: p53, BRCA and cancer. p53 mutation partially rescues developmental arrest in Brca1 and Brca2 null mice, suggesting a role for familial breast cancer genes in DNA damage repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Identification of a RING protein that can interact in vivo with the BRCA1 gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Evidence for a transcriptional activation function of BRCA1 C-terminal region

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

CBP/p300 interact with and function as transcriptional coactivators of BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

BRCA1 required for transcription-coupled repair of oxidative DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Genetic analysis of BRCA1 function in a defined tumor cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

BRCA1 physically associates with p53 and stimulates its transcriptional activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Biological characterization of human epithelial ovarian carcinoma cells in primary culture: the insulin-like growth factor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Comparison of paclitaxel-, 5-fluoro-2'-deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis. Evidence for EGF-induced anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Direct interaction between Ras and the kinase domain of mitogen-activated protein kinase kinase kinase (MEKK1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Ras signalling and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Two CD95 (APO-1/Fas) signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Differential modulation of apoptosis sensitivity in CD95 type I and type II cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Biochemical pathways of caspase activation during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Target protease specificity of the viral serpin CrmA. Analysis of five caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

BRCA1 interacts with components of the histone deacetylase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

BRCA1 regulates p53-dependent gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

A role for Jun-N-terminal kinase in anoikis; suppression by bcl-2 and crmA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

The regulation of anoikis: MEKK-1 activation requires cleavage by caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Epidermal growth factor induction of the c-jun promoter by a Rac pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Suppression of Ras-induced apoptosis by the Rac GTPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Daxx, a novel Fas-binding protein that activates JNK and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Bcl-xL functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200

Transcriptional activation by BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M005824200